If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "NeuroSigma"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | |||
[[Category:Twitter Accounts]] | [[Category:Twitter Accounts]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
| Line 28: | Line 27: | ||
[https://www.crunchbase.com/organization/neurosigma Crunchbase] | [https://www.crunchbase.com/organization/neurosigma Crunchbase] | ||
[https://twitter.com/Neurosigma Twitter] | [https://twitter.com/Neurosigma Twitter] | ||
| − | |||
Revision as of 23:55, 2 February 2024
"NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD."
Founded in The United States around 2008, NeuroSigma produces noninvasive hardware.
NeuroSigma makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TNS
FDA
NeuroSigma has 1 medical devices registered with the FDA. Here are some of them:
| Device ID | Device Name | Class | Category | PMA | PMN |
|---|---|---|---|---|---|
| DEN180041 | Transcutaneous Nerve Stimulator For Adhd | 2 | Neurology | False | True |